
In a study led by my colleague Dr Rostami at Weill Cornell, we demonstrated the impact of genomics in critical ICU care. Nine out of ten ICU patients have genetic mutations that can affect the metabolism of medicines commonly prescribed in the ICU. tinyurl.com/yfn46uy7
English










